Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Medical Marijuana I (OP: MJNA )

0.0060 -0.0005 (-7.69%)
Streaming Delayed Price Updated: 3:59 PM EDT, Oct 2, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Medical Marijuana I

< Previous 1 2 Next >
Historic Ruling To Legalize Cannabis Cultivation In Brazil: These Weed Companies Will Likely Benefit
Following years of stalling on the issue of legal cultivation of cannabis for medicinal and industrial purposes, a Brazilian appeals court is set to rule on allowing businesses and farmers to... 
Via Benzinga
Key Marijuana Executive Changes You Should Know About, New Appointments & More
As the Benzinga Cannabis Capital Conference returns to Miami (April 11-12), gathering top CEOs, investors and leaders in the 
Via Benzinga
CBD For Traumatic Brain Injuries? Oral Administration Reduces Levels Of Neuronal Death In Animal Model, New Study
HempMeds, a subsidiary of Medical Marijuana, Inc. (OTCPK:MJNA) took part in a collaboration on a study to demonstrate the effectiveness of hemp-based CBD in the treatment of Parkinson's Disease. 
Via Benzinga
Medical Marijuana Launches Two New Full Spectrum Concentrations in Brazil With Competitive Price Point
Cannabis company Medical Marijuana, Inc. (OTC: MJNA) announced Tuesday that its subsidiary HempMeds Brasil launched two new full spectrum products in Brazil. 
Via Benzinga
Key Cannabis Exec Changes You Need To Know About: Dutchie Taps New CEO, Illinois' New Cannabis Officer & More
Dutchie Names New CEO Cannabis-tech company Dutchie has named a new CEO, reported Marijuana Business Daily. Executive chair Tim Barash agreed to replace the company's co-founders, brothers Ross and... 
Via Benzinga
Medical Marijuana Eliminates $10M Of Debt From Its Balance Sheet
Medical Marijuana, Inc. (OTC:MJNA) has satisfied and ... 
Via Benzinga
Medical Marijuana Q3 Revenue Declines 37% Sequentially, Here Are The Details
Medical Marijuana, Inc. (OTCPK:MJNA) released its financial results for the quarter ending September 30, 2022, revealing net revenue of $4.9 million, an unfavorable decrease of 37% compared to $7.8... 
Via Benzinga
Argentina's 'Cannabis Conicet' Public Company Seeks To Strengthen The Industry In South America
The government of Argentina created a technology company that aims to boost the medical cannabis and industrial hemp industry. The technology-based public company, the ‘Cannabis Conicet’, will operate... 
Via Benzinga
Medical Marijuana, Inc. Subsidiary HempMeds Mexico Undertakes Promising CBD Research For Parkinson's Treatment
Cannabis company Medical Marijuana, Inc. 
Via Benzinga
Medical Marijuana Signs Distribution Agreement With Complete Hemp Technologies
Kannaway, a subsidiary of Medical Marijuana, Inc. (OTCPK:MJNA), has signed a distribution agreement with long-time partner Complete Hemp Technologies (CHT) to expand its capabilities in the European... 
Via Benzinga
Medical Marijuana Q2 Revenue Declines 18.75% YoY, Here Are The Details
Medical Marijuana, Inc. (OTCPK:MJNA) released financial results for the quarter ending June 30, revealing net revenue of $7.8 million, a decrease of 18.75% compared to 9.6 million in Q2 2021. Q2 2022... 
Via Benzinga
EXCLUSIVE: Medical Marijuana, Inc. Subsidiary HempMeds Working With Argentine Research Hospital On CBD For Adult Epilepsy
Medical Marijuana, Inc. (OTC: MJNA), the first publicly-traded cannabis company to launch cannabis-derived nutraceutical products, brands, and supply chains announced that its subsidiary HempMeds is... 
Via Benzinga
BREAKING: Brazil Supreme Court Authorizes Citizens To Grow Medicinal Cannabis
What Happened? 
Via Benzinga
10 Penny Stocks You Can Have for Less Than a Dime
If you want to lose all your inhibitions and take a swing for the fences, these penny stocks priced under a dime could be for you. 
Via InvestorPlace
Medical Marijuana Launches Pharma Subsidiary In Brazil, Expanding Access To CBD Products In Pharmacies
Medical Marijuana, Inc. (OTCPK: MJNA) has launched its first pharmaceutical subsidiary, HM Pharma, in Brazil. 
Via Benzinga
What's The Future For Cannabis-Infused Edibles?
Cannabis-infused edibles are a booming market. The near-endless array of cannabinoid-rich foods and beverages are coupled with positive sales figures, suggesting that edibles should stick around as a... 
Via Benzinga
Medical Marijuana, Inc. Reports Revenue Of $7.8M For Q1 2022
Medical Marijuana, Inc. (OTCPK:MJNA) released its financial results for the quarter ending March 31, 2022, revealing $7.8 million in net revenue, a 24% increase when compared to the previous quarter.... 
Via Benzinga
With Strong Sales History And Pandemic Restrictions Waning, Cannabis Leaders Discuss 4/20 Market Expectations
It's no secret that cannabis' high holiday, 4/20, is a sales driver. Data provided by firms and various market leaders helps break down the market boom, highlighting core driving demographics and the... 
Via Benzinga
Medical Marijuana Subsidiary Kannaway Reports Largest Revenue In Company History For South Africa Division
Kannaway subsidiary of Medical Marijuana, Inc. (OTCPK:MJNA) achieved its largest revenue month in the company’s history in its South Africa division for March 2022. 
Via Benzinga
Medical Marijuana Subsidiary Kannaway's CBD Products Close To Validation By UK Food Standard Agency
Kannaway, subsidiary of Medical Marijuana, Inc., (OTCPK:MJNA) has been included on the recently published list of brands that have submitted novel foods applications to the UK Food Standard Agencies... 
Via Benzinga
Medical Marijuana Reports $34.1M In 2021 Revenue, Strengthens International Presence
Medical Marijuana, Inc. (OTC: MJNA) has announced its financial results for the year ending December 31, 2021, and provided an overview of recent operational highlights. 
Via Benzinga
Medical Marijuana's Kannaway To Launch Its First CBD Product With 1% THC At Its Event In Prague
Medical Marijuana, Inc. (OTC:MJNA) confirmed Tuesday that 
Via Benzinga
Medical Marijuana's HempMeds Brasil Sponsors Brazilian Obesity Medicine Symposium
HempMeds Brasil subsidiary of Medical Marijuana, Inc. (OTC:MJNA) is sp... 
Via Benzinga
Medical Marijuana's Subsidiary Kannaway Reveals Record Revenue Month For South Africa And Japan Divisions
Medical Marijuana, Inc. (OTC:MJNA) confirmed Tuesday that 
Via Benzinga
Medical Marijuana Promotes Todd Morrow To President
Medical Marijuana, Inc. (OTC: MJNA) announced that the company’s CFO Todd Morrow, has been promoted and will now serve as the company’s president. 
Via Benzinga
Medical Marijuana's Kannaway Expands In South Africa With New Office & Warehouse in Johannesburg
Medical Marijuana, Inc. (OTC: MJNA) announced that its subsidiary Kannaway has opened a new office and warehouse in South Africa. 
Via Benzinga
Cannabis In Poland: Medical Marijuana, Inc.'s Kannaway Opens Office And Warehouse In Warsaw
Medical Marijuana, Inc. (OTC:MJNA), a publicly-traded cannabi... 
Via Benzinga
Cannabis Movers & Shakers: MediPharm Labs, Kannaway, Affinor Growers, The Weldon Project
MediPharm Labs Announces Board Shake-Up CBD-focused pharmaceutical company MediPharm Labs Corp. (TSX: 
Via Benzinga
Topics Cannabis
Exposures Cannabis
The Week In Cannabis: Stocks Down, Republican Legalization Bill, Germany, Uruguay, Earnings, New ETF And More
Below is a recap of the main news related to the cannabis industry and markets for the week of November 15, 2021. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Medical Marijuana Inc's Stock Down On Q3 Results And Slight Revenue Decline
Medical Marijuana, Inc. (OTC:MJNA) reported financial... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.